Cancer Metabolism Researchers explore how cancer cells reprogram their metabolic processes to support rapid growth and survival. This shift in metabolism allows tumors to produce the energy and building blocks necessary for uncontrolled cell division. By studying these altered metabolic pathways, cancer metabolism researchers seek to uncover new targets for therapeutic intervention, aiming to disrupt the energy supply of cancer cells and limit their ability to grow and spread. The work of cancer metabolism researchers is pivotal in developing innovative treatment strategies that combine metabolic disruption with existing therapies like chemotherapy, radiotherapy, and immunotherapy. Targeting specific metabolic enzymes or pathways involved in cancer’s altered metabolism may provide new avenues to "starve" tumors and make them more susceptible to treatment. With this approach, researchers are working towards more effective, personalized therapies with the potential for fewer side effects, as treatments could selectively target the cancer cells’ unique metabolic characteristics. This emerging field offers great promise in reshaping the future of cancer therapy, focusing not only on attacking the cancer itself but also on the metabolic processes that sustain its growth. Unlike normal cells, which mainly rely on oxidative phosphorylation for energy production, many cancer cells preferentially use glycolysis, even when oxygen is available.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China